STAT Summit

News

The Chan Zuckerberg Initiative's new NYC Biohub will develop new bio-engineered immune cells that can aide in early detection of diseases.

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.